Equities research analysts expect LHC Group (NASDAQ:LHCG) to post $0.60 earnings per share for the current quarter, according to Zacks. Four analysts have made estimates for LHC Group’s earnings, with the highest EPS estimate coming in at $0.65 and the lowest estimate coming in at $0.57. LHC Group posted earnings of $0.54 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 11.1%. The business is scheduled to report its next earnings report on Wednesday, November 1st.

On average, analysts expect that LHC Group will report full-year earnings of $2.40 per share for the current fiscal year, with EPS estimates ranging from $2.36 to $2.50. For the next year, analysts expect that the company will post earnings of $2.65 per share, with EPS estimates ranging from $2.60 to $2.75. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that cover LHC Group.

LHC Group (NASDAQ:LHCG) last announced its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.54 by $0.09. The business had revenue of $260.20 million during the quarter, compared to analyst estimates of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. LHC Group’s revenue for the quarter was up 15.1% compared to the same quarter last year. During the same period last year, the company earned $0.52 EPS.

Several analysts have weighed in on LHCG shares. Jefferies Group LLC boosted their price target on shares of LHC Group from $56.00 to $65.00 and gave the stock a “buy” rating in a research note on Monday, May 15th. Zacks Investment Research downgraded shares of LHC Group from a “buy” rating to a “hold” rating in a research note on Thursday, July 6th. Royal Bank Of Canada reissued a “buy” rating and issued a $69.00 price target on shares of LHC Group in a research note on Monday, May 15th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $68.00 price target (up from $55.00) on shares of LHC Group in a research note on Monday, May 8th. Finally, BidaskClub downgraded shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 12th. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. LHC Group presently has a consensus rating of “Buy” and an average price target of $65.75.

ILLEGAL ACTIVITY NOTICE: This news story was reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/08/10/0-60-eps-expected-for-lhc-group-lhcg-this-quarter.html.

In related news, Director Coliseum Capital Management, L sold 8,632 shares of the business’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.25, for a total transaction of $520,078.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Donald Dwayne Stelly sold 3,181 shares of the business’s stock in a transaction dated Thursday, June 8th. The shares were sold at an average price of $64.97, for a total transaction of $206,669.57. Following the transaction, the chief operating officer now owns 114,235 shares in the company, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. Insiders have sold 554,839 shares of company stock worth $34,333,811 in the last quarter. 14.80% of the stock is owned by corporate insiders.

Several institutional investors have recently made changes to their positions in the stock. BlackRock Inc. boosted its position in shares of LHC Group by 18.1% in the second quarter. BlackRock Inc. now owns 2,325,510 shares of the health services provider’s stock valued at $157,879,000 after buying an additional 356,014 shares in the last quarter. FMR LLC boosted its position in shares of LHC Group by 14.1% in the first quarter. FMR LLC now owns 1,619,899 shares of the health services provider’s stock valued at $87,312,000 after buying an additional 199,849 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of LHC Group by 3.9% in the first quarter. Vanguard Group Inc. now owns 1,432,008 shares of the health services provider’s stock worth $77,185,000 after buying an additional 54,279 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of LHC Group by 2.7% in the first quarter. Dimensional Fund Advisors LP now owns 1,262,316 shares of the health services provider’s stock worth $68,039,000 after buying an additional 32,771 shares during the period. Finally, Ameriprise Financial Inc. boosted its stake in shares of LHC Group by 6.7% in the second quarter. Ameriprise Financial Inc. now owns 578,956 shares of the health services provider’s stock worth $39,306,000 after buying an additional 36,218 shares during the period. Institutional investors own 84.97% of the company’s stock.

Shares of LHC Group (NASDAQ:LHCG) traded up 0.33% on Thursday, reaching $63.16. The company had a trading volume of 116,185 shares. The company’s 50-day moving average is $63.76 and its 200-day moving average is $56.72. LHC Group has a one year low of $32.04 and a one year high of $69.35. The company has a market capitalization of $1.15 billion, a PE ratio of 27.95 and a beta of 0.77.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.